PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic extracts showed high effectiveness against L. major promastigotes and amastigotes in vitro [PMID: 19303752, 19508747] and therapeutic benefit in infected mice [PMID: 38787236].
Thioalkaloid-enriched extracts and DTBN caused dose- and time-dependent reduction in proliferation and viability of human AML cells via apoptosis induction [PMID: 35455407].
Leaf extracts (NUP) partially protected mice from LPS-induced and fecal-induced septic shock by inhibiting NF-κB [PMID: 25490314].
DTBN ameliorated kidney damage and inflammation in a mouse model, decreasing serum urea, creatinine, and macrophage infiltration [PMID: 38555397].
Extracts protected cells from acute measles virus infection [PMID: 32260270], and DTBN inhibited SARS-CoV-2 production in Vero E6 cells [PMID: 37176034].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 38787236 (2024) — Anti-Leishmania major Properties of Nuphar lutea (Yellow Water Lily) Leaf Extracts and Purified 6,6' Dihydroxythiobinupharidine (DTBN). · Pathogens (Basel, Switzerland)
- 2.PMID: 32260270 (2020) — Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus. · Molecules (Basel, Switzerland)
- 3.PMID: 19508747 (2009) — Antileishmanial activity in Israeli plants. · Annals of tropical medicine and parasitology
- 4.PMID: 35455407 (2022) — Cytotoxicity of Thioalkaloid-Enriched Nuphar lutea Extract and Purified 6,6'-Dihydroxythiobinupharidine in Acute Myeloid Leukemia Cells: The Role of Oxidative Stress and Intracellular Calcium. · Pharmaceuticals (Basel, Switzerland)
- 5.PMID: 28638458